gvtcx

Provision of iQue Screening Platform

Public Health England Published 16 Feb 2017 Contracts Finder

key details

Value£200,000
Statuscomplete
Category (CPV) 38434510
RegionSouth West
Deadline1 Feb 2017
Contract start16 Feb 2017
Contract end15 Feb 2022
Procedurelimited
SME suitableYes
OCIDocds-b5fd17-285220c5-f9c7-42c2-82d5-ab2dcc5e3851

Award

SupplierValueDateStatus
IntelliCyt Corporation £300,000 16 Feb 2017 active

description

TB Research Group, National Infection Service, Public Health England (PHE) awarded a contract for the provision of iQue screening platform merging high throughput screening with high content flow cytometry to IntelliCyt Corporation.

This purchase is to support the screening of antimicrobial activity on current and novel drugs against Mycobacterium tuberculosis. The iQue Plus Screener is the only instrument on the market capable of the speeds required for this work, as it can analyse samples from a full 96-well plate in

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
16 Feb 2017 Award (award) · cea72286-eaa0-4327-ba24-92e0963d0418-130872

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.